Next generation skin

About the company

Synflora, a research project in the process of being established as a biotech start-up, focuses on studying the human skin microbiome to enhance human health. The human body hosts trillions of microorganisms that interact closely with our cells. We regard the microbiome as an extension of the human host. By integrating its natural capabilities with innovative technologies based on proteins or siRNAs, we aim to develop exclusive treatments for skin conditions.

Technology Skin 2.0

Synflora represents a platform based on engineered skin microbes capable of improving skin health by producing and secreting continuous active molecules within the hair follicle overcoming invasive treatments and low penetration. Synflora is able to produce and deliver therapeutics long term within the skin while being precise and targeted to the site of interest. Our technology enables the treatment of skin conditions by harnessing nature’s capabilities and precise genetic engineering efforts.

Team

Marc Güell Cargol, PhD

Tenure Track Professor and Principal Investigator.
Co-Founder and Scientific Head.
marc.guell@upf.edu

Nastassia Knödlseder, PhD

CEO and co-founder.
Post-doctoral researcher.
nastassia.knoedlseder@upf.edu

MarÍa José Fábrega, PhD

CSO and co-founder.
Post-doctoral researcher.
maria-jose.fabrega@upf.edu

Dr. Aiguader, 88
Barcelona Biomedical Research Park
08003 Barcelona (Spain)